MARKET

CRMD

CRMD

CORMEDIX
AMEX

Real-time Quotes | Nasdaq Last Sale

4.120
-0.260
-5.94%
After Hours: 4.120 0 0.00% 18:42 08/07 EDT
OPEN
4.370
PREV CLOSE
4.380
HIGH
4.400
LOW
3.940
VOLUME
930.38K
TURNOVER
--
52 WEEK HIGH
8.80
52 WEEK LOW
2.160
MARKET CAP
125.95M
P/E (TTM)
-2.2930
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CRMD stock price target is 13.00 with a high estimate of 14.00 and a low estimate of 12.00.

EPS

CRMD News

More
Cormedix's Earnings: A Preview
Benzinga · 8h ago
CorMedix Inc. to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 10
GlobeNewswire · 4d ago
CorMedix slumps after pricing equity offering
CorMedix (NYSEMKT:CRMD) is down 22% premarket on increased volume in reaction to its public offering of ~4.4M common shares at $4.50 per share. Underwriter
seekingalpha · 07/28 18:26
KODK, MARA, NOV and AUDC among midday movers
Seeking Alpha - Article · 07/28 16:41
Ocugen leads healthcare gainers; CorMedix and Heat Biologics among losers
Seeking Alpha · 07/28 15:01
CorMedix shares are trading lower after the company announced a common stock offering with no terms disclosed.
Benzinga · 07/28 14:01
CorMedix Prices 4.44M Share Offering At $4.50/Share
Benzinga · 07/28 13:22
NAK, STM among premarket losers
Seeking Alpha - Article · 07/28 12:15

Industry

Pharmaceuticals
+0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Symbol
Price
%Change

About CRMD

CorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology, and patients receiving total parenteral nutrition, intravenous (IV) hydration, and/or IV medications. Neutrolin is an anti-infective solution for the prevention of catheter-related infections and thrombosis in the central venous catheter markets, such as dialysis, critical care and oncology. Neutrolin is a broad-spectrum antimicrobial/antifungal and anticoagulant combination that is active against common microbes, including antibiotic-resistant strains, and may prevent biofilm formation.
More

Webull offers kinds of CorMedix Inc. stock information, including AMEX:CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.